Gustav Ahlin
- Oncology top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Molecular Biology
- Pharmacology top 2%
- Infectious Diseases top 10%
- Co-authors
- Per ArturssonJohan KarlssonConstanze HilgendorfAnnick SeithelAnna‐Lena UngellChristel A. S. BergströmPär MatssonUlf Norinder
- Topics
- Drug Transport and Resistance Mechanisms (8 papers)HIV/AIDS drug development and treatment (6 papers)Pharmacological Effects and Toxicity Studies (4 papers)
- Journals
- Journal of Medicinal ChemistryJournal of Pharmacology and Experimental TherapeuticsPharmaceutical Research
- Partner nations
- SwedenSingaporeUnited States
In The Last Decade
Gustav Ahlin
7 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 86
- Oncology 813
- Pediatrics, Perinatology and Child Health 389
- Molecular Biology 265
- Pharmacology 245
- Infectious Diseases 141
Countries citing papers authored by Gustav Ahlin
This map shows the geographic impact of Gustav Ahlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustav Ahlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustav Ahlin more than expected).
Fields of papers citing papers by Gustav Ahlin
This network shows the impact of papers produced by Gustav Ahlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustav Ahlin. The network helps show where Gustav Ahlin may publish in the future.
Co-authorship network of co-authors of Gustav Ahlin
This figure shows the co-authorship network connecting the top 25 collaborators of Gustav Ahlin. A scholar is included among the top collaborators of Gustav Ahlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustav Ahlin. Gustav Ahlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 99 | |
| 2 | 129 | |
| 3 | 63 | |
| 4 | Specific and general inhibitors of the three hepatic organic anion transporters OATP1B1 (SLCO1B1), OATP1B3 (SLCO1B3) and OATP2B1 (SLCO2B1) | 1 |
| 5 | 112 | |
| 6 | 143 | |
| 7 | 457 | |
| 8 | 94 |
About Gustav Ahlin
Gustav Ahlin is a scholar working on Infectious Diseases, Oncology and Pediatrics, Perinatology and Child Health, having authored 8 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), HIV/AIDS drug development and treatment (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Oncology (813 citations), Pharmacology (245 citations) and Pediatrics, Perinatology and Child Health (389 citations). Gustav Ahlin has collaborated with scholars based in Sweden, Singapore and United States. Frequent co-authors include Per Artursson, Johan Karlsson, Constanze Hilgendorf, Annick Seithel, Anna‐Lena Ungell, Christel A. S. Bergström, Pär Matsson, Ulf Norinder, Mathias Uhlén and Cristina Al‐Khalili Szigyarto. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.